T45.612
Poisoning by thrombolytic drug, intentional self-harm
Clinical Classification Guidelines
Medical Intelligence & Overview
Poisoning by thrombolytic drugs refers to a situation where an individual intentionally ingests these medications, which are typically used to dissolve blood clots. Such intentional self-harm behaviors can be serious and require prompt medical attention. Thrombolytic drugs, also known as clot-busting medications, play a critical role in treating conditions like stroke or heart attack, but misuse or overdose can lead to severe health complications.
Causes & Symptoms
Clinical Causes: Intentional self-harm or suicide attempt Misunderstanding of medication usage Revenge or malicious intent Psychiatric conditions leading to self-injury Substance abuse or addiction behaviors
Key Symptoms: Excessive bleeding or hemorrhage Blood in urine or stool Bruising or swelling at various sites Low blood pressure Dizziness or fainting Signs of internal bleeding like abdominal distension or pain Rapid heart rate
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of medical history, clinical examination, and laboratory tests. Healthcare professionals may perform:
Treatment Protocols: Management of thrombolytic poisoning requires immediate medical intervention, typically including:
Clinical Advice & FAQs
Billing Guidance
Is T45.612 a billable ICD-10 code?
Yes, T45.612 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T45.612?
Clinical documentation must specify the nature of Poisoning by thrombolytic drug, intentional self-harm and any associated comorbidities for accurate reporting.
Cite this Clinical Reference